Hui Zhang

机构：Eli Lilly (United States) · ORCID：0000-0002-3037-3604

发表论文 110 篇 · 总被引 2608 次 · h-index 27

代表论文

• Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages (2021 · Autophagy · 被引 109)
• GelMA-MXene hydrogel nerve conduits with microgrooves for spinal cord injury repair (2022 · Journal of Nanobiotechnology · 被引 103)
• CDCA4 suppresses epithelial–mesenchymal transtion (EMT) and metastasis in Non-small cell lung cancer through modulating autophagy (2021 · Cancer Cell International · 被引 30)
• Photosensitizer-induced HPV16 E7 nanovaccines for cervical cancer immunotherapy (2022 · Biomaterials · 被引 29)
• Musculoskeletal Pain in Parkinson's Disease (2022 · Frontiers in Neurology · 被引 27)
• Organic pollutant-induced long-distance ROS signaling drives plant systemic acquired acclimation via rhizomicrobiota (2025 · Nature Communications · 被引 26)